Skip to main content

Table 2 Incidence of patients with lung metastases at first metastatic breast cancer diagnosis stratified by breast cancer subtype

From: Clinicopathological characteristics and survival outcomes in patients with synchronous lung metastases upon initial metastatic breast cancer diagnosis in Han population

 

All metastatic patients, N (%)

With lung metastases

Incidence of lung metastases, %

HR+/HER2-

1180 (52.1)

386

32.7

HR−/HER2+

300 (13.3)

116

38.6

HR+/HER2+

365 (16.1)

130

35.6

Triple-negative

418 (18.5)

177

42.3

All subtypes

2263 (100.0)

809

35.7

  1. HR hormone receptor, HER2 human epidermal growth factor receptor 2